Recombinant DNA-binding protein H3-RL

Shipped with Ice Packs
In Stock

Description

Absence of "H3-RL" in Histone Biology and Recombinant Proteins

The search results focus on histone H3 variants (e.g., H3.1, H3.3), post-translational modifications (PTMs), and recombinant histones used in chromatin studies. Key findings include:

  • H3.1 vs. H3.3: H3.1 is replication-dependent (RD), while H3.3 is replication-independent (RI) and deposited via chaperones like HIRA and DAXX .

  • PTMs: Methylation (e.g., H3K4me1, H3K9me3), acetylation (e.g., H3K14ac), and phosphorylation (e.g., H3S31P) are critical for chromatin dynamics and gene regulation .

  • Recombinant Histones: Commercially available recombinant H3 variants include methylated analogs (e.g., H3K4me1) and H3.3 polynucleosomes for enzymatic assays .

No mention of "H3-RL" appears in (a) histone variant nomenclature, (b) PTM databases, or (c) recombinant protein catalogs.

Potential Confusions or Misinterpretations

The term "H3-RL" could stem from:

  • Abbreviation Errors:

    • R-H3: Recombinant histone H3 (e.g., expressed in E. coli) .

    • RL: Non-standard notation; may refer to residues (e.g., arginine-leucine), but no such construct is documented.

  • Misattribution:

    • H3K4me1 (MLA): A recombinant H3 variant with monomethylation at lysine 4, produced via Methylated Lysine Analog (MLA) technology .

    • H3.3 Polynucleosomes: Recombinant chromatin substrates for studying H3.3-specific enzymes .

Related Constructs with Established Data

If "H3-RL" refers to a hypothetical or proprietary construct, below are analogous recombinant proteins with documented functions:

ConstructDescriptionApplicationsSources
H3K4me1 (MLA)Xenopus H3 monomethylated at K4 via chemical alkylation (aminoethylcysteine)Substrate for HMT assays; controls in histone modification studies .
Recombinant Polynucleosomes (H3.3)Human H3.3 in nucleosomal context with plasmid DNA (pG5E4)Enzyme kinetics, inhibitor screening, chromatin remodeling assays .
H3L126M MutantYeast H3 with L126→M mutation; enhanced copper reductase activityStudying nucleosome enzymatic functions and copper metabolism .
H3K14ac-Enhanced NucleosomesNucleosomes with H3K14 acetylation mediated by HMGN1/PCAF .Chromatin accessibility and transcriptional activation studies .

Recommendations for Further Research

To resolve ambiguity, consider:

  1. Clarifying Terminology: Verify if "RL" refers to residues (e.g., R = arginine, L = leucine) or a proprietary code.

  2. Exploring PTMs: Investigate whether "RL" denotes a novel modification (e.g., phosphorylation at S10 and acetylation at K9) .

  3. Consulting Databases: Search histone databases (e.g., H3 Atlas, UniProt) for "RL" annotations.

Product Specs

Form
Lyophilized powder. We will preferentially ship the available format. If you have specific format requirements, please note them when ordering.
Lead Time
Delivery times vary based on purchasing method and location. Consult your local distributor for specifics. All proteins ship with standard blue ice packs. Request dry ice in advance (extra fees apply).
Notes
Avoid repeated freeze-thaw cycles. Working aliquots are stable at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Default glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer, temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon arrival. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you require a specific tag, please inform us and we will prioritize its development.
Synonyms
DNA-binding protein H3-RL; Fragment
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-16
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Rhizobium leguminosarum
Target Protein Sequence
MNKNELVSAV AERAGL
Uniprot No.

Target Background

Function
Histone-like DNA-binding protein that wraps and stabilizes DNA, preventing denaturation under extreme conditions.
Protein Families
Bacterial histone-like protein family

Q&A

What is the optimal expression system for recombinant H3-RL?

Recombinant H3-RL is most effectively expressed in E. coli using the pRSET expression vector system, which generates a His₆-tagged fusion protein of approximately 21 kDa. Research indicates that successful expression can be achieved in standard laboratory strains with the following protocol:

  • Transform expression vector into competent E. coli cells

  • Culture transformants in LB medium containing 50 μg/mL kanamycin at 37°C with shaking at 140 rpm for initial growth

  • Scale up by inoculating 1 mL preculture into 100 mL autoinduction LB medium in a 500 mL baffled flask

  • Incubate at 28°C with shaking at 140 rpm for 24 hours to achieve optimal protein expression

This approach typically yields sufficient quantities of functional protein for downstream applications while minimizing inclusion body formation.

How can the functionality of expressed H3-RL be verified?

Functionality of recombinant H3-RL can be verified using gel mobility shift assays with genomic DNA extracts. When properly expressed and folded, H3-RL binds both single-stranded DNA (ssDNA) and double-stranded DNA (dsDNA). The protocol involves:

  • Prepare genomic DNA extract from plant tissue

  • Incubate purified R-H3 protein with the DNA extract

  • Resolve the mixture by agarose gel electrophoresis

  • Visualize DNA forms by Southern blot hybridization

  • Compare with control samples without R-H3 to observe mobility shifts indicating protein-DNA binding

Successful binding to various DNA forms confirms the functional nature of the E. coli-expressed R-H3 protein and validates its capacity to interact with nucleic acids in a manner similar to native histone H3.

Which regions of H3-RL are critical for protein-protein interactions?

Deletion analysis of histone H3 has revealed that the N-terminal region (residues 1-68) is essential for interactions with partner proteins. Experimental evidence using truncated forms of histone H3 demonstrates:

  • R-H3-ΔC (lacking residues 69-136) maintains interactions with partner proteins

  • R-H3-ΔN (lacking residues 1-68) fails to interact with binding partners

  • The N-terminal domain contains the key residues required for specific protein-protein interactions

This domain mapping provides crucial information for researchers designing experiments to investigate H3-RL interactions with other nuclear proteins or when engineering H3-RL variants with altered binding specificities.

How do post-translational modifications affect H3-RL binding properties?

Post-translational modifications significantly alter the binding properties of H3-RL, creating specific interaction surfaces for partner proteins. Research on histone H3 modifications reveals:

  • Trimethylation of lysine K9 (H3K9me3) creates binding sites for heterochromatin protein 1 (HP1) family proteins

  • Phosphorylation of serine S10 (H3S10ph) modulates these interactions

  • The combination of H3K9me3/S10ph creates unique binding surfaces recognized by specific protein complexes including Atrx, Daxx, and members of the FACT complex

These findings underscore the importance of considering the modification state when designing experiments with H3-RL, as these modifications serve as molecular switches that determine interaction partners.

What methods are most effective for identifying novel H3-RL binding partners?

Multiple complementary approaches should be employed to identify and validate H3-RL binding partners:

Overlay Assays:

  • Separate potential binding proteins by PAGE and transfer to PVDF membranes

  • Probe membranes with ³⁵S-labeled in vitro-translated H3-RL

  • Include appropriate controls (BSA as negative control, core histones as positive control)

  • Visualize interactions through autoradiography

Co-Immunoprecipitation (Co-IP):

  • Mix purified recombinant H3-RL with potential binding partners

  • Add H3-specific polyclonal antiserum

  • Load mixture onto protein G-Sepharose column and incubate for 1 hour

  • Wash extensively to remove non-specific interactions

  • Elute bound proteins and analyze by SDS-PAGE and Western blotting

  • Include controls (preimmune serum, irrelevant proteins like BSA)

These methodologies enable robust validation of protein interactions while minimizing false positives.

How can researchers quantify the binding affinity between H3-RL and partner proteins?

Quantitative assessment of binding affinities requires analytical techniques that measure interaction dynamics:

  • SILAC-based mass spectrometry approach:

    • Culture cells in media containing either light or heavy isotope-labeled amino acids

    • Perform immunoprecipitations from both populations

    • Mix heavy-specific pulldowns with corresponding light isotope controls

    • Analyze by mass spectrometry to determine heavy-to-light (H/L) ratios

    • Normalize against H/L ratio obtained for pulldown of the bait protein

    • Use normalized values to approximate interaction strength

  • Surface Plasmon Resonance (SPR):

    • Immobilize purified H3-RL on sensor chip

    • Flow potential binding partners over the surface at varying concentrations

    • Measure real-time association and dissociation kinetics

    • Calculate binding constants (Ka, Kd) from the resulting sensorgrams

These quantitative approaches provide precise measurements of interaction dynamics that complement qualitative binding assays.

How can H3-RL be used to study virus-host interactions in plant systems?

H3-RL has proven valuable for investigating nucleoprotein interactions during viral infection processes:

  • Express fluorescently tagged H3-RL (H3-ECFP) in plant leaf tissue via Agrobacterium-mediated infiltration

  • Co-express with viral proteins of interest (e.g., NSP-EGFP) or infiltrate with infectious viral clones

  • Monitor protein localization using confocal microscopy

  • Track changes in H3-RL subcellular distribution during viral infection

  • Perform co-immunoprecipitation to isolate complexes containing H3-RL, viral proteins, and viral DNA

Key findings from such experiments reveal:

  • H3-RL relocalization from nucleoplasm to nucleolus in the presence of viral NSP

  • Formation of ring-like structures around the nucleolus when H3-RL colocalizes with NSP

  • Egress of H3-RL from the nucleus to cytoplasmic bodies and plasmodesmata during viral infection

These observations provide valuable insights into the mechanisms of viral movement and genome trafficking between cells.

What controls are essential when studying specificity of H3-RL interactions with viral proteins?

When investigating interactions between H3-RL and viral proteins, stringent controls are necessary to establish specificity:

  • Protein controls:

    • Include structurally similar but functionally distinct proteins (e.g., other basic proteins)

    • Test related viral proteins from different virus families

    • Include non-relevant proteins (BSA) as negative controls

  • Interaction specificity experiments:

    • Compare interactions with MPs from selected plant-infecting RNA viruses (BCMNV HC-Pro, CMV 3a, TMV MP)

    • Verify that interaction is not simply due to similar biochemical properties (e.g., basic nature of proteins)

    • Perform reciprocal experiments (e.g., using NSP as probe against RNA virus MPs)

Experimental evidence shows that despite their basic nature, CMV 3a and TMV MP do not interact with histone H3, confirming the specificity of H3-RL interactions with particular viral proteins rather than representing non-specific interactions between basic proteins.

How can researchers create stable, covalent H3-RL-DNA complexes for structural studies?

Formation of stable, covalent DNA-protein complexes with H3-RL can be achieved using DNA-protein covalent-linking patch (D-Pclip) technology:

  • Design DNA oligonucleotides containing appropriate recognition sequences

  • Express and purify recombinant H3-RL under optimized conditions

  • Mix purified H3-RL with the designed DNA oligonucleotides

  • Allow formation of non-covalent complexes

  • Initiate covalent linkage formation through appropriate catalysis

  • Purify the resulting covalent DNA-protein complexes by chromatography

This approach yields homogeneous, stoichiometrically defined H3-RL-DNA complexes suitable for high-resolution structural analyses and functional studies.

What analytical techniques best characterize H3-RL-DNA complexes?

Multiple complementary techniques should be employed to fully characterize H3-RL-DNA complexes:

Analytical TechniqueInformation ProvidedExperimental Considerations
Size-exclusion chromatographyComplex homogeneity and stoichiometryBuffer conditions critical for complex stability
Native PAGEComplex integrity and mobilityLimited resolution for large complexes
SDS-PAGECovalent vs. non-covalent interactionsDenatures non-covalent complexes
Mass spectrometryPrecise molecular weight, modification mappingSample preparation crucial for accurate analysis
Transmission electron microscopyComplex morphology and organizationNegative staining can introduce artifacts
X-ray crystallographyAtomic-level structural detailsRequires homogeneous, crystallizable samples

Each technique provides unique insights, and their combined application generates comprehensive characterization of H3-RL-DNA complexes.

How can researchers improve solubility of H3-RL during recombinant expression?

Improving H3-RL solubility requires systematic optimization of expression conditions:

  • Expression temperature modification:

    • Lower temperature (16-28°C) generally improves folding and solubility

    • Extended expression time at lower temperature compensates for reduced expression rate

  • Buffer optimization:

    • Include 50 mM Tris-HCl (pH 8.0) as base buffer

    • Add 500 mM NaCl and 10% v/v glycerol to stabilize protein structure

    • Consider addition of low concentrations of non-ionic detergents for extraction

  • Solubility assessment:

    • Separate intracellular soluble fraction by centrifugation (10,000 × g, 5 min, 4°C)

    • Solubilize pellet with 8 M urea for insoluble fraction analysis

    • Compare protein distribution between soluble and insoluble fractions by SDS-PAGE

  • Fusion tag selection:

    • His₆-tag generally provides good purification without affecting solubility

    • Consider solubility-enhancing tags (MBP, SUMO) for particularly difficult constructs

These approaches significantly increase the proportion of H3-RL in the soluble fraction, facilitating downstream purification and applications.

What strategies can address non-specific binding during H3-RL interaction studies?

Non-specific binding represents a significant challenge in H3-RL interaction studies. The following strategies minimize such artifacts:

  • Buffer optimization:

    • Include moderate salt concentration (150-300 mM NaCl) to disrupt ionic interactions

    • Add low concentrations of non-ionic detergents (0.1-0.2% Triton X-100)

    • Include competing agents (BSA, tRNA) to block non-specific binding sites

  • Washing protocol optimization:

    • Perform multiple washes with wash buffer containing 20 mM HEPES (pH 7.9), 150 mM NaCl, 1.5 mM MgCl₂, 0.2 mM EGTA, 0.2% Triton X-100, and 10% glycerol

    • Increase wash stringency progressively to identify optimal conditions

  • Control experiments:

    • Include structurally similar proteins with different functions

    • Perform reciprocal experiments with different tagged versions

    • Use truncated proteins to map interaction domains

These approaches collectively minimize non-specific interactions while preserving biologically relevant binding.

How might researchers utilize H3-RL to study chromatin reorganization during viral infection?

Emerging research opportunities include:

  • Engineer fluorescently-tagged H3-RL variants with specific post-translational modifications

  • Monitor real-time changes in H3-RL localization during viral infection using live-cell imaging

  • Combine with ChIP-seq to identify genomic regions affected by viral-induced chromatin reorganization

  • Perform proteomic analysis of H3-RL-associated complexes at different infection stages

  • Develop H3-RL mutants to disrupt specific virus-host interactions and assess functional consequences

These approaches would provide unprecedented insights into how viruses manipulate host chromatin to facilitate their replication and movement.

What emerging technologies might enhance structural studies of H3-RL in nucleoprotein complexes?

Several cutting-edge technologies show promise for advancing structural studies of H3-RL complexes:

  • Cryo-electron microscopy (cryo-EM):

    • Enables visualization of native-state complexes without crystallization

    • Recent advances allow near-atomic resolution of dynamic complexes

    • Particularly valuable for large nucleoprotein assemblies

  • Integrative structural biology approaches:

    • Combine X-ray crystallography, NMR, and cryo-EM data

    • Incorporate cross-linking mass spectrometry to identify interaction interfaces

    • Use computational modeling to generate comprehensive structural models

  • DNA-protein covalent-linking technologies:

    • D-Pclip technology enables creation of stable, defined complexes

    • Allows capture of transient interaction states

    • Facilitates structural analysis of otherwise dynamic complexes

These technologies promise to reveal unprecedented details about H3-RL's role in nucleoprotein complex formation and function.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.